Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,022 | 5,139 | 8,903 | 11,938 | 16,661 |
| Receivables | 187 | 133 | 379 | 651 | N/A |
| TOTAL | $3,459 | $5,663 | $9,492 | $13,131 | $16,892 |
| Non-Current Assets | |||||
| PPE Net | 39 | 43 | 40 | 41 | 37 |
| Other Non-Current Assets | 63 | 63 | 50 | 0 | 0 |
| TOTAL | $102 | $106 | $90 | $41 | $37 |
| Total Assets | $3,561 | $5,769 | $9,583 | $13,172 | $16,929 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,492 | 2,354 | 3,190 | 3,391 | 3,304 |
| Accounts payable and accrued liabilities | 596 | 1,010 | 809 | 757 | 591 |
| Accrued Expenses | 639 | 948 | 3,361 | 2,404 | 2,152 |
| Other current liabilities | 9 | N/A | 136 | 35 | 125 |
| TOTAL | $2,737 | $4,312 | $7,496 | $6,586 | $6,172 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 611 | 1,488 |
| Other Non-Current Liabilities | 1,250 | 1,250 | 1,500 | 404 | 389 |
| TOTAL | $1,250 | $1,250 | $1,500 | $1,015 | $1,876 |
| Total Liabilities | $3,987 | $5,562 | $8,996 | $7,601 | $8,048 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5 | 4 | 3 | 3 | 3 |
| Common Shares | 11 | 9 | 9 | 9 | 9 |
| Retained earnings | -71,996 | -70,035 | -68,396 | -62,228 | -58,704 |
| TOTAL | $-426 | $207 | $587 | $5,571 | $8,881 |
| Total Liabilities And Equity | $3,561 | $5,769 | $9,583 | $13,172 | $16,929 |